(Total Views: 390)
Posted On: 06/14/2019 6:10:34 PM
Post# of 156886
While still feeling somewhat disappointed about the outcome of the TO there is reason for optimism too.
Cydy has enough cash for the next couple of months.
Because of that there is more time to close (better) deals and some (pre)clinical trial results could become known that could enhance value.
Something like 5% less dilution than with our standard Paulson raises. While not that impressive now it could make quite a difference if we’re talking about a $10, $20, $50, $100 share price. It sure would be nice to get paid an extra $5 per share.
Full steam ahead!
Cydy has enough cash for the next couple of months.
Because of that there is more time to close (better) deals and some (pre)clinical trial results could become known that could enhance value.
Something like 5% less dilution than with our standard Paulson raises. While not that impressive now it could make quite a difference if we’re talking about a $10, $20, $50, $100 share price. It sure would be nice to get paid an extra $5 per share.
Full steam ahead!
(0)
(0)
